Transactions
$75 Million
Sole Bookrunner
Follow-On
February 2020
$150 Million
Joint Bookrunner
Follow-On
February 2020
$238 Million
Joint Bookrunner
IPO
February 2020
$345 Million
Joint Bookrunner
Follow-On
January 2020
$328 Million
Joint Bookrunner
Follow-On
January 2020
$52 Million
Exclusive Placement Agent
Private Placement
January 2020
$1.1 Billion
Financial Advisor
Sale to Eli Lilly
Pending
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of Oncology Division from Human Longevity
January 2020
$35 Million
Joint Bookrunner
Follow-On
January 2020
$295 Million
Joint Bookrunner
Follow-On
January 2020
Up to $100 Million
Exclusive Financial Advisor
Acquisition of Arthrosurface
Pending
Up to $95 Million
Exclusive Financial Advisor
Acquisition of Parcus Medical
Pending
- « Previous Page
- Page 1
- Page 2
- Page 3
- ...
- Page 47
- Next Page »